Ankylosing Spondylitis

>

On the HCPLive ankylosing spondylitis page, resources on the topics of medical news and expert insight into the inflammatory disease can be found. Content includes articles, interviews, videos, podcasts, and breaking news on ankylosing spondylitis, and more.

Latest News

Secukinumab Demonstrates Safety, Efficacy in Patients with Ankylosing Spondylitis, Psoriatic Arthritis
Secukinumab Demonstrates Safety, Efficacy in Patients with Ankylosing Spondylitis, Psoriatic Arthritis

March 31st 2023

Treatment with secukinumab was safe and effective for patients with ankylosing spondylitis and psoriatic arthritis, with significant reductions in disease activity scores observed through 52 weeks.

Older Age, Male Sex Linked to More Severe COVID-19 Outcomes in Rheumatology Patients Treated With Secukinumab
Older Age, Male Sex Linked to More Severe COVID-19 Outcomes in Rheumatology Patients Treated With Secukinumab

November 10th 2022

FDA Approves Adalimumab Biosimilar
FDA Approves Adalimumab Biosimilar

August 17th 2022

Filip Van den Bosch, MD: Safety and Efficacy of Upadacitinib for nr-axSpA
Filip Van den Bosch, MD: Safety and Efficacy of Upadacitinib for nr-axSpA

June 3rd 2022

Video Series
Video Interviews

More News

© 2023 MJH Life Sciences

All rights reserved.